Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2014 pubmed 470 citations

Human antimicrobial peptides and proteins.

Wang. Guangshun G

Key Findings

  • LL-37 is a 37‑amino‑acid cathelicidin that disrupts bacterial membranes via pore formation or a carpet‑like mechanism.
  • Human AMPs show huge diversity in size, charge, and structure, allowing multiple antimicrobial strategies.
  • Various nutrients and environmental factors (vitamin D, zinc, calcium, short‑chain fatty acids, UV‑B, etc.) can up‑regulate the expression of LL‑37 and other AMPs.

Practical Outcomes

  • For self‑experimenters, increasing vitamin D, zinc, calcium, and short‑chain fatty acid intake, or getting regular safe UV‑B exposure, may raise LL‑37 levels and boost innate defense. While LL‑37 itself isn’t yet an over‑the‑counter supplement, understanding its triggers can inform protocols aimed at improving infection resistance and overall immune health.

Summary

Human antimicrobial peptides like LL-37 are natural proteins that help our immune system kill microbes. LL-37 works by inserting into bacterial membranes and forming pores, which destroys the bugs. Its production can be boosted by things like vitamin D, zinc, calcium, short‑chain fatty acids, and UV‑B light, suggesting simple ways to enhance innate immunity.

Abstract

As the key components of innate immunity, human host defense antimicrobial peptides and proteins (AMPs) play a critical role in warding off invading microbial pathogens. In addition, AMPs can possess other biological functions such as apoptosis, wound healing, and immune modulation. This article provides an overview on the identification, activity, 3D structure, and mechanism of action of human AMPs selected from the antimicrobial peptide database. Over 100 such peptides have been identified from a variety of tissues and epithelial surfaces, including skin, eyes, ears, mouths, gut, immune, nervous and urinary systems. These peptides vary from 10 to 150 amino acids with a net charge between -3 and +20 and a hydrophobic content below 60%. The sequence diversity enables human AMPs to adopt various 3D structures and to attack pathogens by different mechanisms. While α-defensin HD-6 can self-assemble on the bacterial surface into nanonets to entangle bacteria, both HNP-1 and β-defensin hBD-3 are able to block cell wall biosynthesis by binding to lipid II. Lysozyme is well-characterized to cleave bacterial cell wall polysaccharides but can also kill bacteria by a non-catalytic mechanism. The two hydrophobic domains in the long amphipathic α-helix of human cathelicidin LL-37 lays the basis for binding and disrupting the curved anionic bacterial membrane surfaces by forming pores or via the carpet model. Furthermore, dermcidin may serve as ion channel by forming a long helix-bundle structure. In addition, the C-type lectin RegIIIα can initially recognize bacterial peptidoglycans followed by pore formation in the membrane. Finally, histatin 5 and GAPDH(2-32) can enter microbial cells to exert their effects. It appears that granulysin enters cells and kills intracellular pathogens with the aid of pore-forming perforin. This arsenal of human defense proteins not only keeps us healthy but also inspires the development of a new generation of personalized medicine to combat drug-resistant superbugs, fungi, viruses, parasites, or cancer. Alternatively, multiple factors (e.g., albumin, arginine, butyrate, calcium, cyclic AMP, isoleucine, short-chain fatty acids, UV B light, vitamin D, and zinc) are able to induce the expression of antimicrobial peptides, opening new avenues to the development of anti-infectious drugs.

Study Information

Provider

pubmed

Year

2014

Date

2014-05-13T00:00:00.000Z

DOI

10.3390/ph7050545

Citations

470

References

334